Semaglutide, a synthetic analog of glucagon-like peptide-1 (GLP-1), has garnered attention for its intriguing properties and potential implications in various r ...

More than 90% of patients achieved clinically meaningful weight reduction compared to placebo in a phase 3 trial of ecnoglutide.

A new review suggests that tirzepatide (Mounjaro, Zepbound) may have neuroprotective mechanisms that could help reduce the ...

A new drug from California-based pharma company Amgen, which has concluded a phase II trial, shows promise as a powerful ...

including TNF-a inhibitors (MYMD-1), androgen receptor agonists (LPCN 1148), proto-oncogene protein c-MAS-1 agonists (Sarconeos), glucagon-like peptide-1 (GLP-1) receptor agonists (Froniglutide), and ...

The Semaglutide peptide has emerged as a compelling subject in biochemical and physiological research due to its potential ...

Because glucagon in animals has positive inotropic and chronotropic effects in the presence of beta-adrenergic blockade, catecholamine depletion or full digitalization, its cardiovascular effects i ...

In diseases due to exposure to toxic particles like gout, macrophages elicit separate pathways for inflammation and lysosomal ...

Scientists at the University of Western Australia and the Perron Institute for Neurological and Translational Science have ...

News Release 17-Jun-2025 New hormonal pathway links oxytocin to insulin secretion in the pancreas Peer-Reviewed Publication Impact Journals LLC image: Figure 2. Relation of Oxt and glucagon.